• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性

[Age-related macular degeneration].

作者信息

Van Bol L, Rasquin F

出版信息

Rev Med Brux. 2014 Sep;35(4):265-70.

PMID:25675629
Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrialized countries in individuals over 65 years of age. It is characterized by a progressive degenerative disorder of the macula, resulting in a loss of the central vision. There are two forms of AMD, the atrophic and the exudative form. A number of risk factors have been implicated in the onset of this condition. With the ageing of the population, the prevalence of AMD is steadily raising and is leading to a growing social and economical burden. Much research has been conducted to improve the diagnosis and management of people at risk of AMD and to develop new treatments. In this review we will discuss the risk factors associated with AMD, the clinical forms and their diagnosis, as well as the current and future therapeutic options.

摘要

年龄相关性黄斑变性(AMD)是工业化国家65岁以上人群不可逆失明的主要原因。其特征是黄斑进行性退行性病变,导致中心视力丧失。AMD有两种形式,萎缩性和渗出性。多种风险因素与该病的发病有关。随着人口老龄化,AMD的患病率在稳步上升,并导致日益加重的社会和经济负担。已经开展了大量研究以改善对有AMD风险人群的诊断和管理,并开发新的治疗方法。在本综述中,我们将讨论与AMD相关的风险因素、临床类型及其诊断,以及当前和未来的治疗选择。

相似文献

1
[Age-related macular degeneration].年龄相关性黄斑变性
Rev Med Brux. 2014 Sep;35(4):265-70.
2
Age-related macular degeneration: a leading cause of blindness.年龄相关性黄斑变性:失明的主要原因。
Med J Aust. 1996 Nov 18;165(10):561-4.
3
[Age-related macular degeneration – a challenge for public health care].
Ther Umsch. 2016;73(2):79-83. doi: 10.1024/0040-5930/a000760.
4
[Therapeutic innovation in AMD and other retinal diseases].[年龄相关性黄斑变性及其他视网膜疾病的治疗创新]
Rev Prat. 2013 Jan;63(1):68-73.
5
[Age-related macular degeneration--contemporary possibilities of treatment].[年龄相关性黄斑变性——当代治疗的可能性]
Acta Medica (Hradec Kralove) Suppl. 2004;47(1):41-5.
6
New treatments for age-related macular degeneration.年龄相关性黄斑变性的新疗法。
Minn Med. 2003 Apr;86(4):40-6.
7
[Age-related macular degeneration].年龄相关性黄斑变性
Rev Prat. 2006 Jun 15;56(11):1194-201.
8
Age-related macular degeneration: current and novel therapies.年龄相关性黄斑变性:现有和新型疗法。
Maturitas. 2010 May;66(1):46-50. doi: 10.1016/j.maturitas.2010.02.006. Epub 2010 Mar 12.
9
Age-related macular degeneration and recent developments: new hope for old eyes?年龄相关性黄斑变性及近期进展:老眼有新希望了?
Postgrad Med J. 2007 May;83(979):301-7. doi: 10.1136/pgmj.2006.052944.
10
Eye Conditions in Older Adults: Age-Related Macular Degeneration.老年人的眼部疾病:年龄相关性黄斑变性
FP Essent. 2016 Jun;445:24-8.